Envita Medical Center is a world-class cancer and Lyme disease treatment center located in Scottsdale, Arizona with over a hundred years of combined research and clinical experience treating the most difficult and complex cases. We at Envita have been helping our patients outperform other renowned cancer centers for nearly two decades; in that time, we have helped thousands of patients who have struggled with late-stage cancer discover targeted treatment options through the use of advanced integrative personalized medicine that are years ahead of what other centers can provide. We do this work with great love and compassion for our patients which we feel is an integral part of the healing process.
Envita Medical Center represents the future of personalized medicine. We specialize in integrating the most modern and effective conventional care with the latest in advanced research-based natural and alternative treatment options. Envita has established this unique, complex, and necessary infrastructure to foster unparalleled healing potential for our patients through many years of hard work and prayer.
To achieve real and lasting progress against your condition; you need a completely personalized, in-depth, multifaceted approach that utilizes the latest advancements in genetic testing to find and hit all the treatment targets that were missed by prior care. Envita offers next-level personalized treatment options by combining our 20 years of experience working with the most difficult cases with the latest advancements in medical technology and in-depth testing to build unique treatment protocols comprehensive to each patient’s individual needs. Personalized medicine is the future of medical treatment and Envita Medical Center is at the forefront of that movement. By utilizing advanced world-class testing and customized medications unique to patients’ needs, we provide a level of personalized care that is unrivaled in the nation and world.
Over the last two decades, Envita Medical Center has been advancing the treatment options for late-stage and complex cancers of all types; we are especially skilled at treating persistent and resistant forms of cancer. Many patients who have struggled with a resistant or persistent form of cancer have been able to achieve breakthroughs at Envita; we have even been successful treating some patients who have been put on hospice by other world-renowned cancer treatment centers.
By incorporating our years of clinical experience with our advanced genetic testing and proprietary treatments, we are better able to identify and treat your cancer on a personalized and customized level. Our cancer treatment is based around research and development. We are always on the forefront of the latest innovations in the world of oncology and continue to innovate on what works and what our patients respond to.
One treatment example that we have seen amazing results with is our proprietary Genetically Targeted Fractionated Chemotherapy treatment, or GTFC, for short. GTFC is a micro-dosed, genetically-targeted chemotherapy that has helped thousands of our patients see lasting progress without the major debilitating side-effects of normal maximum-dose chemotherapy. GTFC is so gentle that many patients report being able to hike and exercise while they are actively receiving treatment. Genetically Targeted Fractionated Chemotherapy is a powerful tool, but it represents only a single piece of our approach at Envita. In our clinical opinion, a comprehensive treatment protocol composed of genetically-targeted chemotherapies, immunotherapies, and epigenetic therapies is essential to achieving lasting results when fighting cancer.
Being effective means treating cancer from many angles and it requires constantly researching and updating our treatments, targets, and delivery techniques to be on the cutting-edge of medicine for our patients. Envita is constantly working to innovate to save lives. One such innovation, CIPI, or Chemo Immuno Percutaneous Injection is an image guided delivery method that is showing great promise. CIPI allows image guided genomic based; chemotherapy, integrative agents, and immunotherapy agents to be placed directly into the tumor using proprietary interventional radiology techniques. This minimally invasive procedure allows for 100% delivery of the targeted agents to the tumors while initiating a systemic immune response for our patient base. Our interventional radiology team has become a part of our vast array of advanced cancer treatment technologies.
Additionally, advanced Interventional radiology is being combined with our proprietary GTFC to provide an intratumoral GTFC that directly injects targeted agents into cancerous tumors. The intratumoral deployment helps to maximize abortion of GTFC directly into the tumor cells, increasing the effectiveness of the medications while reducing the damage to healthy cells.
Most standard systemic or IV chemotherapy programs are only able to get an estimated 4-5% of non-genetically targeted chemotherapy agents absorbed into the cancerous tumors with the vast majority of the medication being dispersed throughout the body causing devastating side-effects with minimal tumor kill and, in some cases, causing multidrug resistance. Envita’s innovation creates a cancer treatment protocol that is highly precise, personalized, and targeted; attacking more genetic biomarkers and using the latest technologies to give your body exactly what it needs to best respond while pursuing lasting and life changing total health and energy.
602 569 4144
8759 E Bell Road, Building G
Scottsdale, Arizona 85260
Leave a Reply